| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 11820 |
| 1 | TOFACITINIB | 4322 |
| 2 | USTEKINUMAB | 3587 |
| 3 | ALBUTEROL SULFATE | 3499 |
| 4 | APREMILAST | 3350 |
| 5 | LENALIDOMIDE | 3230 |
| 6 | SECUKINUMAB | 3157 |
| 7 | VOXELOTOR | 2951 |
| 8 | ERGOCALCIFEROL | 2948 |
| 9 | GUSELKUMAB | 2886 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLODIRSEN | 68 | 0.4024 |
| 1 | CASIMERSEN | 55 | 0.3481 |
| 2 | BACTERIOSTATIC WATER | 47 | 0.2975 |
| 3 | ETEPLIRSEN | 307 | 0.2778 |
| 4 | PEXIDARTINIB | 137 | 0.2665 |
| 5 | VOXELOTOR | 2951 | 0.2638 |
| 6 | GUSELKUMAB | 2886 | 0.2342 |
| 7 | TESAMORELIN | 107 | 0.2341 |
| 8 | TESTOSTERONE ENANTHATE | 144 | 0.1834 |
| 9 | CENOBAMATE | 391 | 0.1703 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 11820 |
| 1 | Interleukin-23 Antagonist [EPC] | 6538 |
| 2 | Corticosteroid [EPC] | 6048 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5055 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 4742 |
| 5 | Kinase Inhibitor [EPC] | 4286 |
| 6 | Thalidomide Analog [EPC] | 3882 |
| 7 | Interleukin-17A Antagonist [EPC] | 3643 |
| 8 | Anti-epileptic Agent [EPC] | 3587 |
| 9 | Interleukin-12 Antagonist [EPC] | 3587 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 11820 | 0.0931 |
| 1 | Human Immunoglobulin G [EPC] | 534 | 0.0894 |
| 2 | CD4-directed Blocking Antibody [EPC] | 25 | 0.0853 |
| 3 | Leptin Analog [EPC] | 62 | 0.0754 |
| 4 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1258 | 0.0736 |
| 5 | Interleukin-23 Antagonist [EPC] | 6538 | 0.0703 |
| 6 | Antisense Oligonucleotide [EPC] | 436 | 0.0668 |
| 7 | Angiopoietin-like 3 Inhibitor [EPC] | 3 | 0.0667 |
| 8 | Recombinant Human Nerve Growth Factor [EPC] | 273 | 0.0666 |
| 9 | Melanocortin 4 Receptor Agonist [EPC] | 2 | 0.0645 |